Proceedings of the Special Committee on
Illegal Drugs
Issue 6 - Minutes of Proceedings
OTTAWA, Monday, September 17, 2001
(11)
[English]
The Special Committee on Illegal Drugs met this day in Room 160-S, Centre Block, at 9:05 a.m., the Chair, the Honourable Pierre Claude Nolin, presiding.
Members of the committee present: The Honourable Senators Banks, Kenny and Nolin (3).
Other senator present: The Honourable Senator Prud'homme (1).
In attendance: From Committees Directorate and Private Legislation: Daniel Charbonneau; Director of Research, Daniel Sansfaçon; and from the Library of Parliament: Gérald Lafrenière.
Also present: The official reporters of the Senate.
Pursuant to the Order of Reference adopted by the Senate on Thursday, March 15, 2001, the committee proceeded to study Canada's anti-drug legislation and policies. (For complete text of Order of Reference see Issue no. 1 of the Proceedings of the Committee.)
WITNESSES:
From the University of Toronto:
Dr. Benedikt Fischer, Professor, Department of Public Health Sciences.
As an individual:
Dr. Perry Kendall, Health Officer.
The Chair made an opening statement.
Dr. Fischer made a statement and answered questions.
At 10:45 a.m., the committee suspended its hearings.
At 10:56 a.m., the committee resumed its hearing.
Dr. Kendall made a statement and answered questions.
At 12:16 p.m., the committee adjourned to the call of the Chair.
ATTEST:
OTTAWA, Monday, September 17, 2001
(12)
[English]
The Special Committee on Illegal Drugs met this day in Room 160-S, Centre Block, at 1:32 p.m., the Chair, the Honourable Pierre Claude Nolin, presiding.
Members of the committee present: The Honourable Senators Banks, Kenny and Nolin (3).
In attendance: From Committees Directorate and Private Legislation: Daniel Charbonneau; Director of Research, Daniel Sansfaçon; and from the Library of Parliament: Gérald Lafrenière.
Also present: The official reporters of the Senate.
Pursuant to the Order of Reference adopted by the Senate on Thursday, March 15, 2001, the committee proceeded to study Canada's anti-drug legislation and policies. (For complete text of Order of Reference see Issue no. 1 of the Proceedings of the Committee.)
WITNESSES:
From the University of British Columbia:
Dr. Richard G. Mathias, Professor, Health Care and Epidemiology Department.
From Prevention Source B.C.:
Dr. Colin R. Mangham, Director.
The Chair made an opening statement.
Dr. Mathias made a statement and answered questions.
At 2:40 p.m., the committee proceed in camera for a discussion on future agenda items.
At 2:56 p.m., the committee returned.
Dr. Mangham made a statement and answered questions.
At 3:32 p.m., the Chair made a closing statement, the committee adjourned to the call of the Chair.
ATTEST:
Blair Armitage
Clerk of the committee